USE OF A PROGESTERONE ANTAGONIST AND OF A GESTAGEN FOR THE TREATMENT OF ENDOMETRIOSIS OR LEIOMYOMATA UTERI

摘要

This invention relates to the use of a product that containsin combination individual dosage units of a competitiveprogesterone antagonist and individual dosage units of a gestagenfor its sequential, oral administration, in which each individualdosage unit that contains the competitive progesterone antagonistcontains the latter in a non-abortion-inducing amount for theproduction of a pharmaceutical agent for treating endometriosisor leiomyomata uteri.